The Scientific Committee of the 23^rd ESVOT Congress invites authors to submit scientific abstracts for podium presentation at Congress.
These should be of original and unpublished work.
Papers from practitioners are particularly welcome.
A maximum of two papers per author will be accepted.

Free communications to be presented in the Main scientific sessions will be evaluated only if pertinent to the topics of the Congress.

MAIN TOPICS FOR 2024 ARE

• Advanced arthroscopy: new concepts
• Arthroplasty
• Feline orthopaedics and traumatology
• Use of guides in corrective osteotomies (incl. 3D printing)
• Future prospective in orthopaedic surgery (virtual reality, augmented reality, robotic assisted surgery)
• Challenging fracture repair Hot topic: elbow joint
• Hot topic: stifle joint
• Regenerative Medicine
• Musculotendinous problems/Sporting Dog Injuries
• Infection in orthopaedics
• Rare orthopaedic diseases (f.e. radial/ulnar necrosis, chondrodysplasia, incomplete ossification of the radial carpal bone, Case reports are also welcomed)

Free Communications must be written and presented in English.
Oral presentations have a 20-minute slot (including 5 min for questions/answers) which may not be exceeded. Abstracts should report recent clinical research; preliminary findings and single case reports will be considered. Reviews will not be accepted.
Research abstracts must have ethical review approval. Research must not have been published nor accepted for publication by the closing date of submission 1 JUNE 2024, 11:59 PM (Rome Time Zone).

All abstracts are reviewed by the Congress Scientific Committee, which reserves the right to select abstracts relevant to the sessions and topics, and decides on the final form of the presentation (oral or poster) and on publication on OrthoVetSuperSite.

Posters related to recent research into any aspect of veterinary orthopaedics and traumatology will be accepted for evaluation by the Scientific Committee.

Once the review process of all submitted abstracts is completed, authors will receive an e-mail informing whether the abstract has been accepted and whether it has been selected for poster or for oral presentation.
All abstract presenters (first author) must register for the Congress and are granted of a 30% reduction on the Congress registration fee. Submitted abstracts will be accepted and published in the conference proceedings only upon receipt of payment.

ABSTRACTS ARE TO BE SUBMITTED ONLINE BY 1 JUNE 2024, 11:59 PM (Rome Time Zone).

Authors whose abstracts have been accepted will be notified by 15 JULY 2024. For abstract submission please go to the ABSTRACT SUBMISSION CENTRE at web site http://abstract.evsrl.it/.

To access the ABSTRACT SUBMISSION CENTRE it is necessary to get a user name and a password for the EGO System.
Should you do not have user name and password, please go to EGO Home Page at http://ego.evsrl.it/.
Username and password will be sent in 2 working days.

The ABSTRACT SUBMISSION CENTRE will guide you filling up the following fields:

1. ABSTRACT FORMAT
A single abstract is required: text length should be max. 8.000 characters including spaces.

2. TITLE
Title of work must be in CAPITAL LETTER, maximum length 180 characters including spaces.

3. SUBJECT

4. ADDRESS FOR CORRESPONDENCE

5. AUTHORS
Max. 7 authors. Mark the presenting author with an asterisk.
Indicate affiliation to an institute with superscript numbering e.g., Smith T1, Patterson C2.
Enter institutes in numerical sequence after the parameter e.g.
1 XXXXXX, 2XXXXXX

6. TEXT AND BIBLIOGRAPHY

7. DISCLOSURE STATEMENT
A conflict of interest statement and/or an involvement (or better financial interest) with products used in the study needs to be stated at abstract submission

ESVOT POLICY ON THE USE OF
ANIMALS IN RESEARCH

ESVOT aims to promote and advance the standards of orthopaedics and traumatology in veterinary species through clinical research and training. We encourage robust clinical and translational research in the area of veterinary orthopaedics.
Such research may often involve prospective or retrospective studies on animals or ex vivo or in vitro studies on animal tissues. Studies on veterinary patients should not involve unnecessary interventions with the sole purpose of research; in other words, all interventions on veterinary patients should be for the intended benefit of the individual animal.
All such research should have local Ethics Committee approval as well as any local, regional or national licences when required; abstracts submitted should state this is the case when indicated.

As a scientific society concerned with the health and welfare of animals, ESVOT acknowledges that sometimes research on animals is necessary for the benefit of human and animal health. However, we strongly support the 3R tenets of Russell and Burch, namely ‘replacement, refinement and reduction’ of animals in research, as supported by the International Council for Laboratory Animal Science (www.iclas.org) and embedded in the European Union Directive 2010/63/EU
(http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:276:0033:0079:EN:PDF).

Moreover, ESVOT will not accept any studies for presentation or publication that involve the use of live dogs, cats, horses or non-human primates in invasive experimentation.